Approved Symbol |
Approved Name |
Source |
Evidence[PMID] |
PLD6 |
phospholipase D family, member 6 |
Mapped by significant region |
|
GJA1 |
gap junction protein, alpha 1, 43kDa |
Mapped by significant region |
|
SLC44A1 |
solute carrier family 44, member 1 |
Mapped by CNV; Mapped by significant region |
|
CYB5B |
cytochrome b5 type B (outer mitochondrial membrane) |
Mapped by CNV |
|
PMAIP1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
Mapped by significant region |
|
NLRX1 |
NLR family member X1 |
Mapped by significant region |
|
MYO19 |
myosin XIX |
Mapped by CNV |
|
SPATA19 |
spermatogenesis associated 19 |
Mapped by significant region |
|
ABCB6 |
ATP-binding cassette, sub-family B (MDR/TAP), member 6 |
Mapped by significant region |
IDA[17006453]
|
OPA1 |
optic atrophy 1 (autosomal dominant) |
Mapped by CNV |
IDA[12504110]
|
BRI3BP |
BRI3 binding protein |
Mapped by CNV |
|
PGAM5 |
phosphoglycerate mutase family member 5 |
Mapped by CNV |
|
CPT1A |
carnitine palmitoyltransferase 1A (liver) |
Mapped by CNV; Mapped by significant region |
|
MAVS |
mitochondrial antiviral signaling protein |
Mapped by CNV |
IDA[18818105]
|
BAD |
BCL2-associated agonist of cell death |
Mapped by significant region |
|
BNIP3 |
BCL2/adenovirus E1B 19kDa interacting protein 3 |
Mapped by CNV |
|
GPAT2 |
glycerol-3-phosphate acyltransferase 2, mitochondrial |
Mapped by LD-proxy |
|
SMCR7 |
Smith-Magenis syndrome chromosome region, candidate 7 |
Mapped by significant region |
|